Novartis Begins Construction Of New Research Centre In San Diego, US
-
Italiano
it
Novartis: a San Diego nasce nuovo centro ricerca biomedica globale
Original
Read more: Novartis: a San Diego nasce nuovo centro ricerca biomedica gl
The new centre is a key pillar of the pharmaceutical group's planned $23 billion (CHF19 billion) investment in the US.
The facility is designed to accelerate the discovery of breakthrough drugs and will become an integral part of Novartis's global research network, which includes sites in Basel, Switzerland, and Cambridge, Massachusetts, the company giant said.
+ Novartis announces billion-dollar investment in US
Researchers will focus on key therapeutic fields such as neuroscience, oncology, age-related diseases and regenerative medicine, exploiting state-of-the-art technology platforms.
“This new research centre will strengthen our scientific leadership and accelerate drug discovery for patients around the world,” said Fiona Marshall, president of Novartis' biomedical research division, in a statement.
A key feature of the facility will be the advanced integration of artificial intelligence (AI) to ensure computational and data analysis capabilities at each stage of the discovery process.
More More Global trade US 'strikes price cut deal' with Swiss pharma giantsThis content was published on Dec 18, 2025 US reportedly strikes deal with Swiss pharmaceutical giants Novartis and Roche to lower drug prices.
Read more: US 'strikes price cut deal' with Swiss pharma g
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment